Drug Name:
CENTRUM KIDS OTC

Generic Name and Formulations:
Vit. A 1500 IU (53% as beta carotene), thiamine 1.5mg, riboflavin 1.7mg, niacin 20mg, pantothenic acid 10mg, pyridoxine 2mg, Vit. B12 6mcg, biotin 45mcg, folic acid 0.4mg, Vit. C 60mg, Vit. D 400 IU, Vit. E 30 IU, Vit. K 10mcg, calcium (as carbonate) 108mg, iron (as carbonyl) 8mg, chromium 20mcg, copper 2mg, iodine 150mcg, magnesium 40mg, zinc 15mg, manganese 1mg, molybdenum 20mcg, phosphorous 50mg; per chew tab; assorted flavors; contains phenylalanine.
Company:
Pfizer Consumer Healthcare
Therapeutic Use:
Indications for CENTRUM KIDS:
Nutritional supplement.
Adults and Children:
<2yrs: not recommended. Take with food. 2–3yrs: ½ tab once daily ≥4yrs: 1 tab once daily.
Contraindications:
Treatment of pernicious or other megaloblastic anemia. Wilson's disease. Hemochromatosis.
Interactions:
Iron, calcium block tetracycline absorption.
How Supplied:
Tabs—80
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Prostate Cancer | Regimens | Drugs |
Rare Cancers | Regimens | |
Renal Cell Carcinoma | Regimens | Drugs |
Skin Cancer | Regimens | Drugs |
Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- A Ketogenic Diet as an Adjunct to Cancer Treatment
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Blinatumomab-Ponatinib Salvage Therapy in B-Cell Acute Lymphoblastic Leukemia: Case Report of Benefit
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Adding Chemotherapy to Radiation Post-Radical Cystectomy Improves Survival in Urothelial Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer